Movicol and Colistimethate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Movicol (polyethylene glycol 3350) and Colistimethate (colistimethate sodium). Common drug interactions include breast cancer among females and rash maculo-papular among males.

The phase IV clinical study analyzes what interactions people have when they take Movicol and Colistimethate. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.

What is Movicol?

Movicol has active ingredients of polyethylene glycol 3350. It is often used in constipation. eHealthMe is studying from 14,249 Movicol users. Check the latest studies of Movicol.

What is Colistimethate?

Colistimethate has active ingredients of colistimethate sodium. eHealthMe is studying from 1,502 Colistimethate users. Check the latest studies of Colistimethate.



On Jul, 11, 2026

35 people who take Movicol and Colistimethate together, and have interactions are studied.

Movicol and Colistimethate drug interactions.

What are the common drug interactions of Movicol and Colistimethate, by gender? *:

female:

  1. Breast cancer

male:

  1. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
  2. Thrombocytopenia (decrease of platelets in blood)
  3. Eosinophilia (eosinophil count in the peripheral blood exceeds)
  4. Leukocytosis (increased white blood cells)
  5. Herpes simplex (herpes simplex is a common viral infection)
  6. Interstitial lung disease
  7. Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system)

What are the common drug interactions of Movicol and Colistimethate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system)

50-59:

  1. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
  2. Thrombocytopenia (decrease of platelets in blood)
  3. Eosinophilia (eosinophil count in the peripheral blood exceeds)
  4. Leukocytosis (increased white blood cells)
  5. Herpes simplex (herpes simplex is a common viral infection)

60+:

  1. Interstitial lung disease

What are the existing conditions these people have? *

  1. Sedation: 30 people, 85.71%
  2. Type 2 Diabetes: 27 people, 77.14%
  3. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 22 people, 62.86%
  4. Diabetes: 6 people, 17.14%
  5. Cystic Fibrosis (disease of the secretary glands): 2 people, 5.71%
  6. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 2 people, 5.71%

* Approximation only. Some reports may have incomplete information.

Do you take Movicol and Colistimethate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Movicol and Colistimethate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Movicol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Colistimethate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Movicol and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Colistimethate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on polyethylene glycol 3350 and colistimethate sodium (the active ingredients of Movicol and Colistimethate, respectively), and Movicol and Colistimethate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: